Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil and finasteride are the only FDA-approved treatments for hair loss caused by genetic and hormonal factors, but their effectiveness is often doubted, indicating a need for new treatments.

The document describes a woman with familial Parkinson's disease due to a genetic mutation, showing severe symptoms and poor response to treatment, and suggests finasteride may help reduce symptoms in Tourette syndrome.

Identifying nonclassic congenital adrenal hyperplasia and carriers of CYP21 mutations is challenging, and genetic counseling is recommended due to their prevalence.

Melasma is now considered a skin aging disorder caused by sun exposure in people with a genetic tendency, which impacts treatment and prevention approaches.

Certain mouse strains develop a skin condition similar to a human hair loss disease due to genetic defects.

A protein called PCBP2 controls the production of a hair growth protein by interacting with its genetic message and is linked to hair loss when this control is disrupted.

An 8-year-old girl has a rare, irreversible hair loss condition caused by a genetic mutation.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

Chemotherapy causes temporary hair loss in women, while Tamoxifen does not significantly affect hair, and genetics show no link between female pattern hair loss and common baldness genes.

Melanoma risk tools need improvement, a gene mutation causes a hair disorder that might be treated by managing cell stress, a potential therapy for a skin-ear disorder involves blocking cell channels, skin wrinkling may indicate lung aging regardless of smoking, and oxidative stress might contribute to common baldness.

More research is needed on better diagnostics, survivorship, and the impact of genetic mutations in lung cancer.

Some blood-thinning medications can increase the risk of bleeding, and certain factors like genetics and other health conditions affect their safety and effectiveness.

The document summarizes medical findings on topics like heart rhythm treatment, sleep apnea therapy, and various health conditions and treatments.

The document concludes that more research is needed to create suitable diagnostic criteria and understand PCOS in Korean women, and genetics may allow for personalized treatment.

Melanoma risk tools need improvement, certain gene mutations cause skin diseases and could be treated by targeting those mutations, skin wrinkling may relate to lung aging due to genetic factors, and oxidative stress affects hair loss but can be reduced in low oxygen.

The document concludes that there have been significant advances in the treatment and diagnosis of various skin conditions.

EGFR helps protect hair follicles from bacterial infections.

Some treatments like minoxidil, finasteride, and dutasteride are effective for hair loss, but there's no agreed best treatment.

Mutations in three genes cause Uncombable Hair Syndrome, leading to frizzy hair that can't be combed flat.

ABCD1 gene mutations cause adrenomyeloneuropathy, leading to symptoms like limb weakness and spasticity, with management focusing on rehabilitation and spasticity treatment.

Activating Nrf2 in skin cells speeds up wound healing by increasing the growth of certain stem cells.

Implanting hair-follicle stem cells in mice brains helped repair brain bleeding and reduced brain inflammation.

Selumetinib effectively reduces tumor size in many children with neurofibromatosis type 1, but can cause skin and hair issues.

The document emphasizes the importance of ongoing research and ethical considerations in genome editing and cellular reprogramming.

CD8A and FOXD2-AS1 may be key for diagnosing and treating alopecia areata.

miR-182 may help treat hallux valgus by targeting FGF9.

Blocking CXCR4 may help treat hidradenitis suppurativa.

The document does not give specific results for hair loss treatment effectiveness.

Cantú syndrome is caused by mutations in the ABCC9 gene.

A 6-year-old girl had both monilethrix and trichorrhexis nodosa, causing brittle hair, with minimal improvement from treatment.